Last updated: July 29, 2025
Introduction
KR102505642 pertains to a South Korean patent granted for pharmaceutical innovations, specifically within the realm of drug development and treatment formulations. Analyzing the scope and claims of this patent provides insights into its protection strategy, potential market coverage, and the evolution of the patent landscape in South Korea’s pharmaceutical sector. This overview aims to deliver a comprehensive assessment tailored for industry stakeholders, patent strategists, and R&D executives.
Patent Overview and Context
Patent KR102505642 was filed with the Korean Intellectual Property Office (KIPO) and grants a monopoly on specific pharmaceutical compounds or formulations. While precise technical specifics depend on the patent document, typical drug patents in South Korea encompass claims that provide exclusive rights over novel compounds, formulations, methods of manufacturing, or therapeutic uses. South Korea’s patent system aligns closely with international standards, providing robust protection for pharmaceutical innovations, especially under patent term extensions and supplementary protection certificates (SPCs).
The patent’s filing date, priority claims, and maintenance status are critical for assessing its current enforceability and strategic positioning within the patent landscape.
Scope of the Patent
1. Technical Sphere
The scope generally encompasses chemical compounds, pharmaceutical compositions, or methods for treating specific medical conditions. Given the patent number, KR102505642 likely covers:
- A novel chemical entity or derivatives thereof.
- A specific formulation enhancing bioavailability, stability, or targeting.
- Therapeutic methods employing the compound(s) against disease indications.
2. Geographical and Legal Scope
The patent offers exclusive rights within South Korea, with potential extensions or equivalents filed in other jurisdictions. The scope also covers related propagation claims, such as uses, manufacturing processes, or dosage methods.
3. Duration and Patent Life
As a utility patent, the term typically extends 20 years from the filing date, with potential extensions if regulatory approval takes longer. Effective management of this lifecycle influences market entry and patent enforcement strategies.
Claims Analysis
1. Types of Claims
The patent likely includes multiple claim types:
- Compound Claims: Covering the chemical entity or its derivatives.
- Use Claims: Methods of treatment or indication-specific applications.
- Process Claims: Manufacturing or formulation methods.
- Formulation Claims: Specific compositions with uniquely structured excipients or delivery systems.
2. Claim Scope and Breadth
- Independent Claims: Set broad protection over the core compound or method.
- Dependent Claims: Narrower, specifying particular modifications, dosages, or combination therapies.
The breadth of independent claims significantly impacts enforcement. Broader claims deter generic development, whereas narrower claims might be easier to design around but offer limited protection.
3. Novelty and Inventive Step
KR102505642 maintains patentability through demonstrating novelty over prior art, possibly by:
- Introducing a structurally unique compound with improved efficacy.
- Presenting an innovative formulation or delivery mechanism.
- Applying the compound in a previously unrecognized therapeutic context.
The inventive step reflects a significant advancement beyond existing drugs or formulations, justifying patent grant.
4. Potential Limitations
Claims may exclude called-for known compounds, prior art, or naturally occurring substances, adhering to Korea’s patent standards favoring genuine innovation. However, overly broad claims risk invalidation if prior disclosures are uncovered.
Patent Landscape of South Korean Pharmaceutical Patents
1. Regional and Global Patent Families
South Korea's pharmaceutical patent environment is dynamic, with active filing by domestic and international companies. Many patents relate to blockbuster drugs, biosimilars, and innovative therapies.
KR102505642 fits within a broader landscape of patents protecting novel drug entities, with significant overlap in chemical space with patents filed by major global pharmaceutical firms, such as Samsung BioLogics, LG Chem, or international players with local subsidiaries.
2. Patent Clusters and Key Players
- Patent Clusters: Innovation tends to cluster around specific therapeutic classes, such as oncology, neurology, or metabolic diseases.
- Dominant Players: Companies like Hanmi Pharmaceutical and SK Biopharmaceuticals frequently file patents similar to KR102505642, aiming to carve out exclusivity in specific niches.
3. Patent Overlap and Litigation Risks
High patent density raises potential for infringement disputes, especially where overlapping claims exist in chemical or formulation aspects. The strategic landscape emphasizes precise claim drafting to carve out enforceable protections while avoiding unnecessary infringement risks.
4. Trends and Innovation Focus
Korean patent filings increasingly emphasize biologics, complex formulations, and personalized medicine approaches. The current patent landscape indicates a shift toward targeting unmet medical needs, complementing global innovation trends.
Implications for Stakeholders
1. For Patent Holders and Innovators
- Strategic Claim Drafting: To maximize exclusivity, claims should balance breadth with specificity.
- Lifecycle Management: Regular patent maintenance, considering potential extensions, enhances market control.
- Global Strategy: Filing equivalents in major jurisdictions strengthens overall patent coverage.
2. For Generics and Competitors
- Patent Landscaping: Analyzing the scope of KR102505642 helps identify potential patent clearance issues.
- Design-Around Strategies: Narrowing claims or developing alternative formulations can mitigate infringement risks.
3. For Regulators and Policymakers
- Encouraging Innovation: Strong patent protection underpins sustainable R&D investment.
- Addressing Patent Thickets: Balancing protection with timely patent expiration facilitates generic entry and consumer access.
Conclusion
KR102505642 exemplifies South Korea’s robust approach to pharmaceutical patent protection, emphasizing innovation, claim precision, and strategic positioning within a competitive landscape. Its scope likely encompasses a novel compound or formulation intended for therapeutic use, protected through a combination of broad and specific claims. The patent landscape is dense and dynamic, with ongoing innovations and patent filings shaping the future of pharmaceutical development in Korea.
Key Takeaways
- Scope Precision: The patent’s strength hinges on well-drafted claims balancing breadth and enforceability.
- Landscape Positioning: Strategic filing and management of KR102505642, along with related patents, are crucial in maintaining market exclusivity.
- Competitive Intelligence: Monitoring surrounding patents ensures avoidance of infringement and guides innovation pathways.
- Lifecycle Optimization: Timely filings, maintenance, and potential extensions preserve patent strength over the drug’s commercial lifecycle.
- Global Considerations: Translating South Korean protection into international patent rights maximizes market opportunities and mitigates risks.
Frequently Asked Questions
Q1: What is the typical process for obtaining a patent patent KR102505642 in South Korea?
A1: The process involves filing a detailed application with claims outlining the invention, followed by examination to assess novelty, inventive step, and industrial applicability. Upon approval, the patent is granted, typically within 12–18 months, provided all requirements are met.
Q2: How does the scope of claims in KR102505642 influence its enforceability?
A2: Broad, well-defined claims provide stronger enforceability, deterring generic competitors. Conversely, overly broad claims risk invalidation if challenged based on prior art, while narrow claims offer limited protection.
Q3: Are there risks of patent infringement for companies developing similar drugs in Korea?
A3: Yes. Companies must conduct thorough patent landscape analyses to identify overlapping claims and avoid infringement. Designing around existing claims or licensing technology are common strategies.
Q4: How can patent KR102505642 be extended or strengthened?
A4: Through subsequent filings, such as method-of-use patents, formulation patents, or filing international equivalents (e.g., via the Patent Cooperation Treaty), companies can broaden their protection and market reach.
Q5: What trends are shaping the future of pharmaceutical patents in South Korea?
A5: Trends include increased filings in biologics, personalized medicine, and combination therapies. Emphasis on pioneering formulations and targeted treatments also reflect Korea’s innovation priorities.
References
- Korean Intellectual Property Office (KIPO). Patent KR102505642.
- World Intellectual Property Organization (WIPO). Patent landscape reports on South Korea.
- Patent Cooperation Treaty (PCT) filings and international patent strategies in South Korea.
- Industry reports on pharmaceutical R&D and patent trends in South Korea.
